Pacific Biosciences of California
PACB
2.72
+0.02
+0.74%
Pacific Biosciences of California
US · PACB
#3373 by market cap
2.72
+0.02
+0.74%
Live - 5344 symbols - heartbeat 440s ago
· 2026-10-08 09:10
Pre-market
2.65
-2.57%
After-hours
2.70
-0.74%
Overnight
2.72
0.00%
- Market cap
- 845.46M
- P/E (TTM)i
- -6.48
- P/Bi
- -25.42
- EPSi
- -1.82
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on PACB?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 4 analysts
Buy
Avg price target
2.08 -23.5%
Price target rangecurrent 2.72
Low1.25
Avg2.08
High3.00
Buy 50%
Hold 25%
Sell 25%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | -- | SELL | 1.25 |
| 2026-09-11 | CCORF | -- | BUY | -- |
| 2026-08-17 | CCORF | -- | BUY | 3.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 3.00 |
| 2026-08-06 | CCORF | -- | BUY | 3.00 |
| 2026-08-06 | Piper Sandler | -- | HOLD | 2.00 |
| 2026-08-05 | Barclays | -- | SELL | 1.25 |
| 2026-05-08 | TD Cowen | -- | BUY | 3.00 |
| 2026-05-08 | CCORF | -- | BUY | 3.00 |
| 2026-05-08 | Piper Sandler | -- | HOLD | 2.00 |
| 2026-05-08 | Barclays | -- | SELL | 1.50 |
| 2026-04-14 | Barclays | -- | SELL | 1.00 |
| 2026-03-19 | CCORF | -- | BUY | 3.00 |
| 2026-03-06 | Barclays | -- | SELL | 1.50 |
| 2026-02-13 | CCORF | -- | BUY | 3.00 |
| 2026-02-13 | Piper Sandler | -- | HOLD | 2.00 |
| 2026-02-13 | Barclays | -- | HOLD | 2.00 |
| 2026-02-12 | TD Cowen | -- | BUY | 3.00 |
| 2026-02-12 | CCORF | -- | BUY | 3.00 |
| 2026-02-12 | Guggenheim | -- | HOLD | -- |
| 2026-02-05 | Piper Sandler | -- | HOLD | 2.00 |
| 2026-01-26 | CCORF | -- | BUY | 3.00 |
| 2026-01-13 | CCORF | -- | BUY | 3.00 |
| 2026-01-07 | TD Cowen | -- | BUY | 3.00 |
| 2025-11-11 | Piper Sandler | -- | HOLD | 2.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Barclays moved from Hold to Sell on 2026-03-06.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-03-06 | Barclays | HOLD → SELL | 1.50 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | After close | -- | -10.38% |
| 2026/Q1 | 2026-05-07 | After close | ±14.52% | -14.55% (beat) |
| 2025/Q4 | 2026-02-12 | After close | ±19.02% | -7.07% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±16.97% | -7.05% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±24.37% | +7.14% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±34.67% | -6.67% (in line) |
| 2024/Q4 | 2025-02-13 | After close | ±27.30% | +25.00% (in line) |
| 2024/Q3 | 2024-11-07 | After close | ±36.45% | -6.12% (in line) |
| 2024/Q2 | 2024-08-07 | After close | ±41.83% | +9.15% (in line) |
| 2024/Q1 | 2024-05-09 | After close | ±32.50% | +2.91% (in line) |
| 2023/Q4 | 2024-02-15 | After close | ±24.89% | -13.94% (in line) |
| 2023/Q3 | 2023-10-30 | After close | ±24.94% | -13.08% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 09:10:31 · For reference only, not investment advice and not tailored to your situation.